Page last updated: 2024-09-04

carbapenems and Fever of Unknown Origin

carbapenems has been researched along with Fever of Unknown Origin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beeker, A; Coenen, JLLM; de Jonge, NA; de Kreuk, A; Herbers, AH; Janssen, JJWM; Kramer, MHH; Lissenberg-Witte, B; Sikkens, JJ; van Agtmael, MA; Vasmel, W; Ypma, P; Zweegman, S	1

Trials

1 trial(s) available for carbapenems and Fever of Unknown Origin

Article	Year
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial. The Lancet. Haematology, 2022, Volume: 9, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carbapenems; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Research; Treatment Outcome	2022

Article

Year

Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial.

The Lancet. Haematology, 2022, Volume: 9, Issue:8

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carbapenems; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Research; Treatment Outcome

2022